Pancreatic Cancer Research

ResearcherWuhan UniversityActive in the last 2 years

Xiaoli Chen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5130974668. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. The RASSF1C-HIF-1α axis drives macrophage lipid metabolism to promote pancreatic cancer. Co-author DOI 10.1038/s41419-026-08609-0↗
  2. miR-324-5p Contributes to Cell Proliferation and Apoptosis in Pancreatic Cancer by Targeting KLF3. Co-author DOI 10.1016/j.omto.2020.07.011↗
  3. MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L. First author DOI 10.1177/1533033820945801↗
  4. miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer. Co-author DOI 10.2147/cmar.s235794↗
  5. Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ. Co-author DOI 10.1016/j.omtn.2017.12.002↗
  6. miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Co-author DOI 10.1093/carcin/bgy074↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ting Zhan · 6 shared papers, 2018–2026 · strength 0.74
  2. Xiaodong Huang · 5 shared papers, 2018–2020 · strength 0.47
  3. Tian Xia · 5 shared papers, 2018–2020 · strength 0.47
  4. Xiaodong Huang · 1 shared paper, 2026 · strength 0.27
  5. Yu Ding · 2 shared papers, 2018–2020 · strength 0.19
  6. Yi-Yuan Wan · 2 shared papers, 2018–2020 · strength 0.18
  7. Yadong Zhang · 1 shared paper, 2020 · strength 0.10
  8. Yadong Zhang · 1 shared paper, 2018 · strength 0.09
  9. Zhongxin Lu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.